Related Experiment Videos
[Panic attacks with cycloleptic course--differential diagnostic considerations in differentiating panic disorder from
1Psychiatrische Universitätsklinik, Bonn.
Psychiatrische Praxis
|July 1, 1996
Summary
Carbamazepine effectively treated panic attacks in a patient unresponsive to antidepressants and benzodiazepines. This suggests a potential role for carbamazepine in managing specific panic attack presentations.
Area of Science:
- Neurology
- Psychiatry
Background:
- Panic attacks are a common psychiatric condition.
- Standard treatments include antidepressants and benzodiazepines.
- Some cases present with atypical features, such as a cycloleptic course.
Observation:
- A patient experienced short-duration, cycloleptic panic attacks.
- Initial treatment with antidepressants and benzodiazepines was ineffective.
Findings:
- Carbamazepine treatment led to significant improvement in panic attacks.
- This highlights carbamazepine's efficacy in specific panic attack subtypes.
Implications:
- Carbamazepine may be a viable therapeutic option for refractory panic attacks.
- The findings support considering epileptic seizures in the differential diagnosis of panic disorder.
- Further research is warranted to explore carbamazepine's role in panic disorder management.